Home › Research › Down syndrome and Alzheimer's
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications
Eikelenboom P, Rozemuller AJ, Hoozemans JJ, Veerhuis R, van Gool WA.. Alzheimer disease and associated disorders, 2000-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
In Alzheimer disease brains, the amyloid plaques are closely associated with a locally induced, nonimmune-mediated, chronic inflammatory response without any apparent influx of leukocytes from the blood. The present findings indicate that in cerebral A beta diseases (Alzheimer disease, Down syndrome, hereditary cerebral hemorrhage with amyloidosis-Dutch type), the clinical symptoms are determined to a great extent by the site of inflammatory response. It was found that the formation of the amyloid-microglia complex seems to be a relatively early pathogenic event that precedes the process of severe destruction of the neuropil. The idea that inflammation is implicated in Alzheimer pathology has received support from the epidemiologic studies indicating that the use of anti-inflammatory drugs can prevent or retard the Alzheimer disease process. In this contribution, we review the relationship between inflammation and clinical manifestation and the opportunities for anti-inflammatory treatments in Alzheimer disease.
What this study adds
Evidence grade: Low
This is a narrative review. This review argues that inflammation around amyloid plaques is an early event in Alzheimer disease and that anti-inflammatory drugs might prevent or slow the disease based on epidemiologic studies. It presents no new trial results, so whether anti-inflammatory treatment actually helps patients remains unproven.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Eikelenboom, P., Rozemuller, A. J., Hoozemans, J. J., Veerhuis, R., & van Gool, W. A. (2000). Neuroinflammation and Alzheimer disease: clinical and therapeutic implications. Alzheimer disease and associated disorders. https://doi.org/10.1097/00002093-200000001-00009
Vancouver
Eikelenboom P, Rozemuller AJ, Hoozemans JJ, Veerhuis R, van Gool WA. Neuroinflammation and Alzheimer disease: clinical and therapeutic implications. Alzheimer disease and associated disorders. 2000. doi:10.1097/00002093-200000001-00009. PMID: 10850731.
BibTeX
@article{eikelenboom2000-10850731,
author = {Eikelenboom, P. and Rozemuller, A. J. and Hoozemans, J. J. and Veerhuis, R. and van Gool, W. A.},
title = {{Neuroinflammation and Alzheimer disease: clinical and therapeutic implications}},
journal = {Alzheimer disease and associated disorders},
year = {2000},
doi = {10.1097/00002093-200000001-00009},
pmid = {10850731},
url = {https://doi.org/10.1097/00002093-200000001-00009}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In Alzheimer disease brains, the amyloid plaques are closely associated with a locally induced, nonimmune-mediated, chronic inflammatory response without any apparent influx of leukocytes from the blood.
- The present findings indicate that in cerebral A beta diseases (Alzheimer disease, Down syndrome, hereditary cerebral hemorrhage with amyloidosis-Dutch type), the clinical symptoms are determined to a great extent by the site of inflammatory response.
Why it matters
This review argues that inflammation around amyloid plaques is an early event in Alzheimer disease and that anti-inflammatory drugs might prevent or slow the disease based on epidemiologic studies. It presents no new trial results, so whether anti-inflammatory treatment actually helps patients remains unproven.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer disease and associated disorders) |
| Journal's citation record | 1 / 4 | Alzheimer Disease & Associated Disorders: journal h-index 131 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2000 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 78 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.8 citations a year over 28 year(s) since 2000 |
| Impact for its field and year | 3 / 6 | Cited 4.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Willem A. van Gool: h-index 70 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Vrije Universiteit Amsterdam: institution h-index 1,014 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 10850731) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Down syndrome and Alzheimer's from nearby years
Also in Down syndrome and Alzheimer's
12 studies in the library are filed under Down syndrome and Alzheimer's with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Down syndrome and Alzheimer's hub.